Can you envision a world where precision medicine transforms healthcare as we know it? Tune in to this exciting episode of BioTalk with Rich Bendis, featuring Dr. Amrie Grammer, Co-Founder of Ampel BioSolutions. In this enlightening discussion, Dr. Grammer unveils the secrets behind Ampel's remarkable success in precision medicine, making this episode a must-listen. Learn about the groundbreaking genomic tests developed by Ampel, providing decision support for autoimmune diseases, and delve into the role of artificial intelligence in predicting potential treatments.
Explore the immense potential for a revolution in healthcare as Dr. Grammer shares insights on understanding the human genome and Ampel's cutting-edge work in harnessing Big Data and Machine Learning for personalized precision medicine. Don't miss this great episode and gain valuable insights into the future of data-driven health.
Rip Ballou, GSK Global Vaccines (EP.14)
Matt Brady, Scheer Partners (EP.13)
Margaret Anderson, Deloitte Consulting (EP.12)
BioHealth Capital Region Forum: Part 2 - Todd Haim, NIH and Matthew McMahon, NIH
BioHealth Capital Region Forum: Part 1 - Jim Jackson, Emergent BioSolutions and Jim Hughes, University of Maryland, Baltimore
Christy Wyskiel, Johns Hopkins University (EP.11)
Lily Qi, Office of Montgomery County Executive (EP.10)
David Petr, Montgomery County Economic Development Corporation (MCEDC) (EP.09)
Rachel King, GlycoMimetics, Inc. (GMI) (EP.08)
Dr. Jay Perman, University of Maryland, Baltimore (UMB) (EP.07)
George Davis, Maryland Technology Development Corporation (TEDCO) (EP.06)
Jonathan Cohen, 20/20 GeneSystems Inc. (EP.05)
Kurt Newman, M.D., Children’s National Health System (EP.04)
Tami Howie, Maryland Tech Council (EP.03)
Daniel Abdun-Nabi, Emergent BioSolutions (EP.02)
Douglas Liu, QIAGEN (EP.01)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money